Vanguard Group’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $55.8M | Buy |
|
|||||
|
2025
Q2 | $31.7M | Sell |
|
|||||
|
2025
Q1 | $17.9M | Buy |
|
|||||
|
2024
Q4 | $25.9M | Buy |
|
|||||
|
2024
Q3 | $32.5M | Sell |
|
|||||
|
2024
Q2 | $22.6M | Buy |
|
|||||
|
2024
Q1 | $39.6M | Buy |
|
|||||
|
2023
Q4 | $20.7M | Sell |
|
|||||
|
2023
Q3 | $15.7M | Buy |
|
|||||
|
2023
Q2 | $13.9M | Buy |
|
|||||
|
2023
Q1 | $9.37M | Buy |
|
|||||
|
2022
Q4 | $9.11M | Buy |
|
|||||
|
2022
Q3 | $4.31M | Sell |
|
|||||
|
2022
Q2 | $6.33M | Sell |
|
|||||
|
2022
Q1 | $8.78M | Buy |
|
|||||
|
2021
Q4 | $24M | Buy |
|
|||||
|
2021
Q3 | $33.4M | Buy |
|
|||||
|
2021
Q2 | $21.8M | Sell |
|
|||||
|
2021
Q1 | $30.8M | Buy |
|
|||||
|
2020
Q4 | $29.4M | Buy |
|
|||||
|
2020
Q3 | $10.7M | Sell |
|
|||||
|
2020
Q2 | $14.5M | Buy |
|